why choose us

First received: July 12, 2022

Clinical Trial: Cardioneuroablation for the Treatment of Vagally-mediated Atrial Fibrillation.

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Atrial Fibrillation Paroxysmal

Study Type: Observational


Official Title: Right Anterior Ganglionated Plexus Ablation Without Pulmonary Vein Isolation for the Treatment of Vagally-mediated Paroxysmal Atrial Fibrillation.

Brief Summary: Pulmonary vein isolation (PVI) is a cornerstone for catheter ablation of atrial fibrillation (AF), however, exact mechanisms of PVI efficacy remain debatable. It has been postulated that in patients with increased vagal tone AF can be treated by attenuation of parasympathetic drive to the heart using cardioneuroablation (CNA) by means of radiofrequency (RF) of the ganglionated plexi, however, data in literature and guidelines are lacking. The objective of this study is to examine the mid-term efficacy of RF-CNA…

Read more